Opfer, Roland https://orcid.org/0000-0002-9911-5478
Ostwaldt, Ann-Christin
Walker-Egger, Christine
Manogaran, Praveena
Sormani, Maria Pia
De Stefano, Nicola
Schippling, Sven
Article History
Received: 12 January 2018
Revised: 19 February 2018
Accepted: 4 March 2018
First Online: 16 March 2018
Compliance with ethical standards
:
: S Schippling reports receiving research Grants from Novartis and Sanofi Genzyme; and consulting and speaking fees from Biogen, Merck Serono, Novartis, Sanofi Genzyme, and Teva. P Manogaran and C. Walker-Egger received travel support from Sanofi Genzyme and Merck Serono. N de Stefano has received honoraria and consultation fees from Merck Serono S.A., Teva Pharmaceutical Industries, Novartis Pharma AG, BayerSchering AG, Sanofi-Aventis and Serono Symposia International Foundation. MP. Sormani received consulting fees from Biogen Idec, Merck Serono, Teva, Genzyme, Roche, Novartis, GeNeuro and Medday.
: All patients gave written informed consent. The study was approved by the Ethics Board of the Canton of Zurich (KEK-ZH-Nr. 2013-0001).